Mr. Kennedy, I appreciate that, but the last point to be made, I suppose, is from constituents, when they say they want to make sure that something like this never happens again, where we face a situation like this and we don't have the necessary national security fundamental to our domestic manufacturing capacity for vaccines.
When it comes to Medicago, Precision NanoSystems, Variation Biotechnologies and the Biologics Manufacturing Centre, can you walk us through, briefly at least, the investments that we are making to make sure this never happens again?